BioNTech CEO Sahin

HK advisers split over buying BioNTech’s 2nd-gen booster

eAwaz Medicine

Hong Kong – Government health advisers in Hong Kong divided if the country should buy BioNTech’s Omicron-targeted coronavirus booster shot, as some said it was more effective than the first-generation jabs, while others claimed the purchase would be a waste of resources. This came amid Hong Kong recording first  Omicron XBB.1 subvariant that came from outside. Health officials dismissed any …

Pfizer BioNTech COVID 19 vaccine

Pfizer-BioNTech Submits to EMA for Omicron Bivalent Vaccine Booster

eAwaz Medicine

MAINZ — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for a 10-µg booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for children 5 through 11 years of age. This application for a variation of the marketing authorization (MA) to include the Omicron BA.4/BA.5-adapted bivalent vaccine in this …

Mixing vaccines

Current booster shots effective against Omicron

eAwaz Medicine

New York – Omicron sub-variants evades antibody responses from Covid vaccines but a new lab study suggests that the current booster doses can be effective. University of Washington researchers saw the functional impact of mutations in  Omicron sub-variants. They used Moderna, Pfizer, Novavax, Janssen, AstraZeneca, Sinopharm, and Sputnik V vaccines. All two-dose vaccines, except for Janssen’s single dose vaccine were …

BA.1 and BA.2 sub lineages.

PHAC continues to monitor Covid-19 epidemiological

eAwaz Health

Ottawa – The Covid-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks. Through the Wellness Together Canada online portal, people of all ages across the country can access immediate, free and confidential mental health and substance use supports, 24 hours a day, seven days a week. PocketWell, …

Modernas mRNA 1273.214


eAwaz Medicine

CAMBRIDGE – Moderna, Inc. has announced new clinical data on its bivalent (Omicron) COVID booster candidate, mRNA-1273.214. One month after administration in previously vaccinated and boosted participants, a 50 µg booster dose of mRNA-1273.214 elicited potent neutralizing antibody responses against the Omicron subvariants BA.4 and BA.5 in all participants regardless of prior infection. Based on this and prior data, the …

Moderna 1

Moderna hopes to offer updated Covid-19 boosters in fall

eAwaz Medicine

Washington – Moderna is set to offer updated Covid-19 boosters in the fall that combine its original vaccine with protection against the Omicron variant. Before Omicron, Moderna was studying a combination shot for protection against an earlier variant named Beta. Moderna is now saying people given that Beta-original vaccine combination produced more antibodies capable of fighting several variants including Omicron than …

Covid 19 vaccines

Covid-19 vaccines continue to protect against hospitalization

eAwaz Medicine

DC – Covid-19 vaccination continues to help protect adults against severe illness with Covid-19 , including hospitalizations and death, according to two reports released in today’s MMWR. During Omicron, Covid-19 -associated hospitalization rates increased for all adults, regardless of vaccination status, but rates were 12 times higher among adults who were unvaccinated compared to adults who received a booster or …

Omicron 2

Omicron may cause brain complications

eAwaz Health

Moscow – The Omicron strain of the Covid-19 may lead to neurological complications much like other Covid variants, according to the Russian expert, founder and chief executive of DNKOM research center Andrey Isaev. He added Omicron can lead to long Covid in adults and systemic inflammations among children, TASS news agency reported.